Biobanking, Laboratory Analytics, and Associated Informatics Services for NIH Biorepositories
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NATIONAL INSTITUTES OF HEALTH NIDA
Contract Value
Not provided
Codes & Classification
Solicitation Number
75N98026R00175SB
NAICS
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Classification Code
AN11
Additional Details
The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), has issued a Small Business Sources Sought Notice seeking information from qualified small business entities regarding their capabilities to provide comprehensive biobanking, laboratory analytics, and associated informatics services for NIH biorepositories. This notice, identified by procurement number 75N98026R00175SB, is intended solely for market research and planning purposes and does not constitute a solicitation or a request for proposals.
**Purpose and Scope**
The primary objective of this market research is to identify capable small businesses that can support the operation, consolidation, and potential recompete of one or more NIH-funded biorepositories for fiscal year 2028. At a minimum, this includes the NIDA Center for Genetic Studies (NCGS), the NIH Brain Development Cohorts (NBDC) Biobank—which supports the Adolescent Brain Cognitive Development (ABCD) Study—and the HEALthy Brain and Child Development (HBCD) Study. NIH currently manages over 20 biorepositories across more than 10 Institutes and Centers, each storing thousands to millions of biospecimens. These repositories are critical to advancing research into biological and environmental factors affecting health, development, and disease.
**Key Requirements and Expected Deliverables**
Respondents must demonstrate extensive experience and technical capability in the following areas:
1. **Sample Management and Storage**
- Secure, humidity- and temperature-controlled storage and tracking for at least 3.5 million biospecimens, adhering to Best Practices, Clinical and Laboratory Standards, and Good Laboratory Practice (GLP; 21 CFR 58).
- Capacity for expansion beyond the minimum storage requirement.
- Positive chain of custody, issue tracking, and resolution of data/sample discrepancies.
- Receipt and management of de-identified clinical, diagnostic, environmental, and phenotypic data.
- Centralized, cost-effective distribution of biosamples to qualified investigators.
- Provision of collection kits, barcoded supplies, and training for research staff.
- CAP Biorepository Accreditation is preferred.
2. **Data Curation and Management**
- Development and maintenance of SOPs for all aspects of sample handling.
- Maintenance of an internal relational database (e.g., using RRIDs) for sample and participant tracking, with computerized inventory management.
- Data cleaning, standardization, and harmonization across diagnostic systems (e.g., RDOC, DSM, ICD), including integration of electronic health records where applicable.
- Transfer of data and sample IDs to controlled-access repositories or data centers.
3. **Laboratory and Analytic Capabilities**
- Laboratory expertise in molecular biology, DNA/RNA extraction, cell line transformation, tissue/cell culture, and rigorous quality control.
- Capabilities for metabolic, hematologic, and clinical assays; high-throughput genotyping, sequencing, and gene-expression analysis; mass spectrometry; advanced genomic and cellular techniques; iPSC/neural stem cell line generation; CRISPR/Cas9 gene editing; and analysis of FFPE tissue.
- Scientific and technical expertise to evaluate researcher requests for biospecimens.
- Experience in biobanking, LIMS, and database management.
- Storage and processing of histopathological tissue samples and primary cell banking.
4. **Informatics and Cyberinfrastructure**
- Development, management, and enhancement of biorepository web portals (front-end and back-end), including features for sample discovery, resource advertisement, and user outreach.
- Maintenance of backend infrastructure (e.g., server maintenance, microservices, relational databases) and front-end UI/UX.
- Compliance with FISMA-level and NIH security requirements, including Authority to Operate (ATO) and security documentation.
- Maintenance and development of APIs and secure, interoperable data exchange infrastructure.
- Capabilities for homomorphic encryption and distributed learning.
5. **Collaboration and Governance**
- Strong collaborative relationships with NIH Data Centers, study teams, and Institutes/Centers.
- Participation as a co-signatory on Specimen/Material Transfer Agreements.
- Eligibility for a Certificate of Confidentiality and compliance with all human subjects protection, ethical, privacy, and data security regulations.
**Submission Requirements**
Interested small businesses must submit a detailed capability statement that addresses:
- Relevant experience, including previous similar projects and techniques employed.
- Professional qualifications of personnel with expertise in biomedical research.
- Description and availability of facilities and equipment.
- Ability to coordinate and administer interrelated tasks effectively and in a timely manner.
- Supporting documentation such as past contracts, references, and awards.
Organizations lacking all required expertise may identify intended collaborators or subcontractors to fulfill the requirements.
**Contracting Entity and Classification**
- **Contracting Entity:** National Institutes of Health (NIH), NIDA
- **Department:** U.S. Department of Health and Human Services
- **NAICS Code:** 541714 – Research and Development in Biotechnology (except Nanobiotechnology), with a small business size standard of 1,000 employees or fewer.
- **Product Service Code:** AN11
**Procurement Type and Set-Aside**
This is a Small Business Sources Sought Notice. Only small businesses under NAICS 541714 should respond. The notice is intended to inform future acquisition strategy, including the potential for small business set-asides and socioeconomic set-aside considerations (e.g., 8(a), Veteran-owned, HUBZone, SDB, women-owned).
**Special Considerations**
- The Government has determined that the requirements do not currently meet the definition of a commercial product or service under FAR 2.101. However, vendors who believe otherwise may submit a written justification.
- This notice is for information gathering only and does not obligate the Government to issue a solicitation or award a contract.
- All submissions must be electronic; paper or faxed statements will not be accepted.
**Contact Information and Submission Instructions**
- **Primary Contact:** Shaun Rostad, Contract Specialist, [email protected], 301-594-9516
- **Secondary Contact:** Joshua T. Lazarus, Contract Specialist, [email protected]
- **Submission Deadline:** October 20, 2026, by 1:00 p.m. EST
- **Notice URL:** [SAM.gov Opportunity](https://sam.gov/opp/92f333de6eb04c65bee45b76b3f3c0e5/view)
**Conclusion**
This notice represents a significant opportunity for small businesses with advanced capabilities in biobanking, laboratory analytics, and informatics to support NIH’s critical biorepository infrastructure. Interested parties should carefully review the detailed requirements and ensure their capability statements comprehensively address all technical areas, personnel qualifications, and facility resources. Collaboration with other organizations is permitted to meet the full scope of requirements. All responses will inform the Government’s acquisition strategy for these essential services.